PERAZODIN

This brand name is authorized in Cyprus, Hong Kong, Malta, Singapore

Active ingredients

The drug PERAZODIN contains one active pharmaceutical ingredient (API):

1 Dipyridamole UNII 64ALC7F90C - DIPYRIDAMOLE

Dipyridamole is an antithrombotic agent with antiplatelet activity. Dipyridamole has an antithrombotic action based on its ability to modify various aspects of platelet function, such as platelet aggregation, adhesion and survival, which are factors associated with the initiation of thrombus formation. Read about Dipyridamole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PERAZODIN Coated tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC07	Dipyridamole	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 65543
Country: MT	Medicines Authority	Identifier(s): MA084/01701, MA084/01702, MA084/01703
Country: SG	Health Sciences Authority	Identifier(s): 00470P, 00739P